JONES WILLIAM A JR has filed 6 insider transactions across 3 companies since June 2024.
Most recent transaction: a grant/award of 14461 shares of Apogee Therapeutics, Inc. ($APGE) on June 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2025 | Apogee Therapeutics, Inc. | $APGE | JONES WILLIAM A JR | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 5, 2025 | Annexon, Inc. | $ANNX | JONES WILLIAM A JR | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| Jan. 9, 2025 | Annexon, Inc. | $ANNX | JONES WILLIAM A JR | Not found | A | Stock Option (Right to Buy) | 88000 | $0.00 | 88,000.0000 | 137,404,145 | 9999.99% | 0.06% |
| Jan. 7, 2025 | NewAmsterdam Pharma Co N.V. | $NAMS | JONES WILLIAM A JR | Chief Commercial Officer | A | Ordinary Shares | 43000 | $0.00 | 43,000.0000 | 94,358,067 | 9999.99% | 0.05% |
| Jan. 2, 2025 | NewAmsterdam Pharma Co N.V. | $NAMS | JONES WILLIAM A JR | Chief Commercial Officer | A | Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 94,358,067 | 9999.99% | 0.21% |
| June 5, 2024 | Apogee Therapeutics, Inc. | $APGE | JONES WILLIAM A JR | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |